Date Document
17/12/2018 AusCann Leadership Transition Update
27/11/2018 Results of Annual General Meeting
27/11/2018 Annual General Meeting Presentation
13/11/2018 AC8 Moves First Products to Commercial Manufacturing Site
30/10/2018 September 2018 Quarterly Activities and Cashflow Report
26/10/2018 Annual Report
26/10/2018 Notice of Annual General Meeting/Proxy Form
02/10/2018 AusCann Releases Cannabinoid Medical Education Resources
01/10/2018 AusCann Joint Venture Signs MoU with Khiron Life Sciences
27/09/2018 Pharmaceutical Executive Joins AusCann Board & Appendix 3X
27/09/2018 AusCann Announces Leadership Transition
24/09/2018 Appendix 4G and 2018 Corporate Governance Statement
24/09/2018 30 June 2018 Annual Financial Report
12/09/2018 AusCann Commences Trading on US OTCQX Market
31/08/2018 Progress Towards Production of Cannabinoid Medicines in FY18
31/08/2018 Appendix 4E and Preliminary Final Report
16/08/2018 Successful Pilot Study of Final Dose Cannabinoid Capsules
13/08/2018 Change of Director's Interest Notice - B. McHarrie
09/08/2018 Appendix 3B
09/08/2018 AusCann Share Purchase Plan Raises $1.9m
31/07/2018 June 2018 Quarterly Activities and Cashflow Report
19/07/2018 Share Purchase Plan (SPP) Offer Document
19/07/2018 Response to ASX Aware Query
16/07/2018 AusCann Share Purchase Plan
13/07/2018 Appendix 3B & s708A(5)(e) Notice
05/07/2018 AusCann Completes A$33.4 million Placement
03/07/2018 Trading Halt
25/06/2018 Australian Production Accelerates with Canadian Engagements
20/06/2018 Response to ASX Price and Volume Query
07/06/2018 AusCann Joint Venture Harvests Second Crop in Chile
15/05/2018 Appendix 3B & s708A(5)(e) Notice
04/05/2018 Appendix 3B & s708A(5)(e) Notice
02/05/2018 Appendix 3B & s708A(5)(e) Notice
26/04/2018 March 2018 Quarterly Activities and Cashflow Report
24/04/2018 AusCann and Canopy Growth Partnership Expansion
28/03/2018 Immediate access for Chilean patients
19/03/2018 Appendix 3B and s708A(5)(e) Notice
28/02/2018 AusCann Builds Momentum in H1 FY18
28/02/2018 Appendix 4D and 31 December 2017 Half Year Report
12/02/2018 s708A(5)(e) Notice
12/02/2018 Appendix 3B
31/01/2018 December 2017 Quarterly Activities and Cashflow Reports
22/01/2018 HoA signed with Leading Wholesale Distributor in Australia
19/01/2018 Appendix 3B - Release from Escrow
17/01/2018 World Class Cannabis Research in Australia
16/01/2018 Release of Securities from Escrow
09/01/2018 Appendix 3B
04/01/2018 Federal Government to Allow Cannabis Export